Announcement Summary: Resonance Health Limited has issued 10,865,432 Performance Rights on February 27, 2026. These securities are not intended to be quoted on the ASX. The Performance Rights have a 3-year retention vesting period, after which recipients have 12 months to exercise them before they convert to fully paid ordinary shares. Any unexercised Performance Rights will expire after this period. Following this issue, the total number of fully paid ordinary securities on the ASX for Resonance Health Limited is 474,792,647. Additionally, there are unquoted securities including 10,000,000 options expiring in 2029 and 23,334 Performance Rights. Investors are welcome to ask any questions they may have about this announcement.